SCHEMBL29592

SCHEMBL29592

CO[PH](=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7126703 0.96
Methane SCHEMBL8679400 0.96
SCHEMBL29130615 0.96
Ammonia Solution, Strong SCHEMBL10785340 0.96
SCHEMBL2406802 0.96
SCHEMBL11337548 0.96
SCHEMBL3310164 0.96
SCHEMBL7120704 0.96
SCHEMBL9282800 0.96
Phosphine SCHEMBL28052730 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12167 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630827-B2 Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies ROGCON, INC. (US) 2026-05-19 US claimed
US-12623188-B2 Forward osmosis driven by electrolysis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-05-12 US claimed
US-20260103714-A1 ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF CANAVAN DISEASE CONTERA PHARMA AS (DK) 2026-04-16 US claimed
EP-4426859-B1 PRIMER SETS AND METHODS AND KITS INCORPORATING THE PRIMER SETS ILLUMINA INC (US) 2026-04-15 EP claimed
EP-4720283-A1 OLIGONUCLEOTIDES TARGETING GAL3ST1 Contera Pharma A/S (DK) 2026-04-08 EP claimed
US-20260085315-A1 POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER APTAH BIO INC (US) 2026-03-26 US claimed
US-12584136-B2 Aptamers for personal health care applications THE PROCTER & GAMBLE COMPANY (US) 2026-03-24 US claimed
US-12584135-B2 Aptamers for personal health care applications THE PROCTER & GAMBLE COMPANY (US) 2026-03-24 US claimed
US-20260035703-A1 Compositions and Methods for Correcting Limb Girdle Muscular Dystrophy Type 2C Using Exon Skipping UNIV CHICAGO (US) 2026-02-05 US claimed
US-20260022377-A1 POLYNUCLEOTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF NEURODEGENERATIVE DISEASES APTAH BIO INC (US) 2026-01-22 US claimed
EP-0281390-A2 Polycationic supports for nucleic acid purification, separation and hybridization GEN-PROBE INCORPORATED (US) 1988-09-07 EP claimed
US-4757055-A Binding herpes virus with nonionic oligonucleoside alkyl or arylphosphonate complementary to base sequence of virus THE JOHNS HOPKINS UNIVERSITY (US) 1988-07-12 US claimed
US-4702849-A ADDING ANIONIC AMINOPHOSPHATE; SURFACE ABSORPTION REDUCES WETTING HALLIBURTON COMPANY (US) 1987-10-27 US claimed
EP-0234910-A2 Method of increasing hydrocarbon productions from subterranean formations HALLIBURTON COMPANY (US) 1987-09-02 EP claimed
EP-0132168-B1 ESTERS OF CYCLOPROPANECARBOXYLIC ACIDS BEARING A CYANO GROUP, PREPARATION PROCESS AND INTERMEDIATES, THEIR USE AS PESTICIDES AND COMPOSITIONS CONTAINING THEM ROUSSEL-UCLAF (FR) 1987-06-16 EP claimed
EP-0132168-A1 Esters of cyclopropanecarboxylic acids bearing a cyano group, preparation process and intermediates, their use as pesticides and compositions containing them ROUSSEL-UCLAF (FR) 1985-01-23 EP claimed
US-4405427-A PHOSPHORYLATED AMIDE MCDONNELL DOUGLAS CORPORATION (US) 1983-09-20 US claimed
US-4276234-A TRANSESTERIFICATION, METHYL IODIDE, MAGNESIUM CHLORIDE OR ALUMINUM CHLORIDE CATALYSTS STAUFFER CHEMICAL COMPANY (US) 1981-06-30 US claimed
US-4272457-A ANTIOXIDANTS, FIRE RETARDANTS ATO CHIMIE (FR) 1981-06-09 US claimed
US-4129588-A Selective manufacture of anhydrous modifications of methyl phosphonic acid and use thereof in making pure methyl phosphonic acid and salts thereof THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-12-12 US claimed